Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -54,664 | -24,455 | -5,226 | N/A |
| Depreciation Amortization | 1,993 | 1,189 | 1,628 | N/A |
| Other Working Capital | 87 | 1,456 | 122 | N/A |
| Other Operating Activity | 32,316 | 7,139 | -851 | 0 |
| Operating Cash Flow | $-20,268 | $-14,671 | $-4,327 | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -19,002 | N/A | N/A | N/A |
| PPE Investments | -135 | -47 | -34 | N/A |
| Investing Cash Flow | $-19,137 | $-47 | $-34 | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | N/A | 25,000 | 3,846 | N/A |
| Debt Repayment | -32 | -31 | -53 | N/A |
| Common Stock Issued | 60,305 | N/A | 0 | N/A |
| Other Financing Activity | 1,195 | -1,965 | -5 | 0 |
| Financing Cash Flow | $61,468 | $23,004 | $3,788 | $N/A |
| Beginning Cash Position | 10,255 | 1,969 | 2,542 | N/A |
| End Cash Position | 32,318 | 10,255 | 1,969 | N/A |
| Net Cash Flow | $22,063 | $8,286 | $-573 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -20,268 | -14,671 | -4,327 | N/A |
| Capital Expenditure | N/A | -47 | -51 | N/A |
| Free Cash Flow | -20,268 | -14,718 | -4,378 | 0 |